Jong Joseph Kim - Net Worth and Insider Trading

Jong Joseph Kim Net Worth

The estimated net worth of Jong Joseph Kim is at least $2 Million dollars as of 2024-04-25. Jong Joseph Kim is the CEO of Inovio Pharmaceuticals Inc and owns about 166,807 shares of Inovio Pharmaceuticals Inc (INO) stock worth over $2 Million. Details can be seen in Jong Joseph Kim's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jong Joseph Kim has not made any transactions after 2021-02-03 and currently still holds the listed stock(s).

Transaction Summary of Jong Joseph Kim

To

Jong Joseph Kim Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jong Joseph Kim owns 1 companies in total, including Inovio Pharmaceuticals Inc (INO) .

Click here to see the complete history of Jong Joseph Kim’s form 4 insider trades.

Insider Ownership Summary of Jong Joseph Kim

Ticker Comapny Transaction Date Type of Owner
INO Inovio Pharmaceuticals Inc 2021-02-03 director & Chief Executive Officer

Jong Joseph Kim Latest Holdings Summary

Jong Joseph Kim currently owns a total of 1 stock. Jong Joseph Kim owns 166,807 shares of Inovio Pharmaceuticals Inc (INO) as of February 3, 2021, with a value of $2 Million.

Latest Holdings of Jong Joseph Kim

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INO Inovio Pharmaceuticals Inc 2021-02-03 166,807 10.13 1,688,921

Holding Weightings of Jong Joseph Kim


Jong Joseph Kim Form 4 Trading Tracker

According to the SEC Form 4 filings, Jong Joseph Kim has made a total of 6 transactions in Inovio Pharmaceuticals Inc (INO) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Inovio Pharmaceuticals Inc is the sale of 13,542 shares on February 3, 2021, which brought Jong Joseph Kim around $2 Million.

Insider Trading History of Jong Joseph Kim

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jong Joseph Kim Trading Performance

GuruFocus tracks the stock performance after each of Jong Joseph Kim's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jong Joseph Kim is 20.27%. GuruFocus also compares Jong Joseph Kim's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jong Joseph Kim within 3 months outperforms 7 times out of 12 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jong Joseph Kim's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jong Joseph Kim

Average Return

123.21%

Average return per transaction

Outperforming Transactions

50%

6 out of 12 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.14 20.27 110.16 123.21 77.89 42.45
Relative Return to S&P 500(%) 2.63 18.29 102.22 104.9 61.59 28.67

Jong Joseph Kim Ownership Network

Ownership Network List of Jong Joseph Kim

No Data

Ownership Network Relation of Jong Joseph Kim


Jong Joseph Kim Owned Company Details

What does Inovio Pharmaceuticals Inc do?

Who are the key executives at Inovio Pharmaceuticals Inc?

Jong Joseph Kim is the director & Chief Executive Officer of Inovio Pharmaceuticals Inc. Other key executives at Inovio Pharmaceuticals Inc include Chief Medical Officer Michael John Sumner , Chief Scientific Officer Laurent Humeau , and CFO Peter Kies .

Inovio Pharmaceuticals Inc (INO) Insider Trades Summary

Over the past 18 months, Jong Joseph Kim made no insider transaction in Inovio Pharmaceuticals Inc (INO). Other recent insider transactions involving Inovio Pharmaceuticals Inc (INO) include a net sale of 17,501 shares made by David B. Weiner , and a net sale of 5,700 shares made by Lota S. Zoth .

In summary, during the past 3 months, insiders sold 0 shares of Inovio Pharmaceuticals Inc (INO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,933 shares of Inovio Pharmaceuticals Inc (INO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,933 shares.

Inovio Pharmaceuticals Inc (INO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Inovio Pharmaceuticals Inc Insider Transactions

No Available Data

Jong Joseph Kim Mailing Address

Above is the net worth, insider trading, and ownership report for Jong Joseph Kim. You might contact Jong Joseph Kim via mailing address: 660 W. Germantown Pike, Suite 110, Plymouth Meeting Pa 19462.

Discussions on Jong Joseph Kim

No discussions yet.